Pacira BioSciences Inc
PCRX
ISIN null / Valor 12338490
Pacira BioSciences Inc
UMushroom community rating:
About company
Pacira BioSciences, Inc. (NASDAQ: PCRX) is a specialty pharmaceutical company that develops and commercializes non‑opioid, postsurgical pain management therapies built around its proprietary DepoFoam drug‑delivery technology; its flagship product, EXPAREL (bupivacaine liposome injectable suspension), is used by hospitals, ambulatory surgery centers and surgical specialists to provide prolonged local analgesia and reduce perioperative opioid use. The company markets its products through a targeted sales force to anesthesiologists, surgeons and perioperative teams, pursues regulatory approvals and label expansions to broaden clinical use, and maintains a research and development pipeline to extend its delivery platform to additional formulations and indications, while operating both in the United States and select international markets.
Summarized from source with an LLMView SourceSector: HealthcareKey figures
Performance
Volatility
1042 M
Market cap (USD)
553,346
Daily traded volume (Shares)
19.4 / 18.895
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
